Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shang Yi

Showing results (321-330 of 357) with videos related to

Pageof 36
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 19, 2018
Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation RegistryTzu-Chuan Huang, Shang-Yi Huang, Ming Yao, et al.
Blood|March 2, 2013
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemiaChieh-Lung Cheng, Hsin-An Hou, Ming-Cheng Lee, et al.
Blood|October 8, 2009
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterationsJih-Luh Tang, Hsin-An Hou, Chien-Yuan Chen, et al.
Plos One|June 11, 2015
High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in TaiwanJih-Luh Tang, Hsiang-Chi Kung, Weng-Chi Lei, et al.
Clinical Epigenetics|April 6, 2018
Dynamics of <i>DNMT3A</i> mutation and prognostic relevance in patients with primary myelodysplastic syndromeMing-En Lin, Hsin-An Hou, Cheng-Hong Tsai, et al.
British Journal of Haematology|January 21, 2017
Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trialJin Lu, Jae H Lee, Shang-Yi Huang, et al.
Blood|August 31, 2012
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolutionShang-Ju Wu, Yuan-Yeh Kuo, Hsin-An Hou, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 15, 2022
Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosisHui-Hua Hsiao, Yi-Chang Liu, Hui-Ching Wang, et al.
Annals of Hematology|February 8, 2019
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registriesVania T M Hungria, Jae Hoon Lee, Angelo Maiolino, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 14, 2025
Joint position statement of the diagnosis and management of light chain amyloidosis and light chain cardiac amyloidosis by the Taiwan Society of Cardiology (TSOC) and the Hematology Society of Taiwan (HST)Yen-Wen Wu, Chao-Hung Wei, Yen-Hung Lin, et al.
Pageof 36

Showing results (321-330 of 357) with videos related to

Sort By:
Pageof 36
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 19, 2018
Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation RegistryTzu-Chuan Huang, Shang-Yi Huang, Ming Yao, et al.
Blood|March 2, 2013
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemiaChieh-Lung Cheng, Hsin-An Hou, Ming-Cheng Lee, et al.
Blood|October 8, 2009
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterationsJih-Luh Tang, Hsin-An Hou, Chien-Yuan Chen, et al.
Plos One|June 11, 2015
High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in TaiwanJih-Luh Tang, Hsiang-Chi Kung, Weng-Chi Lei, et al.
Clinical Epigenetics|April 6, 2018
Dynamics of <i>DNMT3A</i> mutation and prognostic relevance in patients with primary myelodysplastic syndromeMing-En Lin, Hsin-An Hou, Cheng-Hong Tsai, et al.
British Journal of Haematology|January 21, 2017
Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trialJin Lu, Jae H Lee, Shang-Yi Huang, et al.
Blood|August 31, 2012
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolutionShang-Ju Wu, Yuan-Yeh Kuo, Hsin-An Hou, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 15, 2022
Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosisHui-Hua Hsiao, Yi-Chang Liu, Hui-Ching Wang, et al.
Annals of Hematology|February 8, 2019
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registriesVania T M Hungria, Jae Hoon Lee, Angelo Maiolino, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 14, 2025
Joint position statement of the diagnosis and management of light chain amyloidosis and light chain cardiac amyloidosis by the Taiwan Society of Cardiology (TSOC) and the Hematology Society of Taiwan (HST)Yen-Wen Wu, Chao-Hung Wei, Yen-Hung Lin, et al.
Pageof 36